The Arginine Methyltransferase PRMT5 Regulates Maintenance and TKI Resistance of Self-Renewing FLT3-ITD AML LSC

被引：0
|
作者：
Kumar, Harish [1 ]
Mohamed, Mostafa [2 ]
Dhir, Aditi [1 ]
Burslem, George M. [3 ]
Zhao, Xinyang [1 ]
Lu, Rui [4 ]
Ahn, Erin [2 ]
Bhatia, Ravi [5 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL USA
[3] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA USA
[4] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, Birmingham, AL USA
[5] Univ Alabama Birmingham, Div Hematol & Oncol, Birmingham, AL USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-205644
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1391 / 1392
页数：2
相关论文
共 11 条
  • [1] PRMT5 Inhibition Enhances Elimination of FLT3-ITD AML Stem Cells in Combination with TKI Treatment
    Kumar, Harish
    Dhir, Aditi
    Paterson, Andrew J.
    Anderson, Nick R.
    Qiu, Shaowei
    Zhao, Xinyang
    Lu, Rui
    Bhatia, Ravi
    BLOOD, 2022, 140 : 3073 - 3074
  • [2] The AML-Associated FLT3-ITD Kinase Regulates Histone Modifications and Cytokine Signaling, Via Effects on PRMT5
    Ando, Koji
    Hamard, Pierre-Jacques
    Liu, Fan
    Martinez, Concepcion
    Ban, Yuguang
    Chen, Xi
    Nimer, Stephen D.
    BLOOD, 2016, 128 (22)
  • [3] Role of Autophagy in Resistance of FLT3-ITD AML Stem Cells to FLT3 TKI Treatment
    Qiu, Shaowei
    Yan, Chengcheng
    Paterson, Andrew J.
    Li, Hui
    Anderson, Nick
    Abraham, Ajay
    He, Jianbo
    Shah, Mansi
    Agarwal, Puneet
    Yang, Jing
    Xie, Min
    Lu, Rui
    Welner, Rob S.
    Bhatia, Ravi
    BLOOD, 2019, 134
  • [4] Role of Enhanced Autophagy in Resistance of FLT3-ITD AML Stem Cells to FLT3 TKI Treatment
    Qiu, Shaowei
    Paterson, Andrew J.
    Abraham, Ajay
    He, Jianbo
    Shah, Mansi
    Agarwal, Puneet
    Mullen, Amanda K.
    Li, Hui
    Harris, Mason W.
    Anderson, Nicholas R.
    Bhatia, Ravi
    BLOOD, 2018, 132
  • [5] An Epigenetic Screen Identifies PRMT5 As a Target for Inhibition of FLT3-ITD AML Cell Growth in Combination with Tyrosine Kinase Inhibitors
    Dhir, Aditi
    Paterson, Andrew J.
    Qiu, Shaowei
    Mullen, Amanda K.
    Anderson, Nick R.
    Bhatia, Ravi
    BLOOD, 2019, 134
  • [6] Proteasomal alterations in a newly created model of FLT3-ITD positive AML with acquired pan-TKI resistance
    Wilson, Katie
    Irwin, Mary E.
    Chandra, Joya
    CANCER RESEARCH, 2014, 74 (19)
  • [7] The Unfolded Protein Response Mediates Resistance in AML and Its Therapeutic Targeting Enhances TKI Induced Cell Death in FLT3-ITD + AML
    Jaquet, Timo
    Preisinger, Christian
    Buetow, Marlena
    Tillmann, Stefan
    Chatain, Nicolas
    Huber, Michael
    Koschmieder, Steffen
    Kirschner, Martin
    Jost, Edgar
    Bruemmendorf, Tim H.
    Kharabi, Bezhad
    Appelmann, Iris
    Schemionek, Mirle
    BLOOD, 2021, 138
  • [8] Integrin αvβ3 Engagement Regulates Glucose Metabolism and Migration through Focal Adhesion Kinase (FAK) and Protein Arginine Methyltransferase 5 (PRMT5) in Glioblastoma Cells
    Che, Pulin
    Yu, Lei
    Friedman, Gregory K.
    Wang, Meimei
    Ke, Xiaoxue
    Wang, Huafeng
    Zhang, Wenbin
    Nabors, Burt
    Ding, Qiang
    Han, Xiaosi
    CANCERS, 2021, 13 (05) : 1 - 16
  • [9] Tackling TKI resistance in AML: A commentary on "Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML." by Yamatani et al.
    Ng, Ozden Hatirnaz
    Eskazan, Ahmet Emre
    TRANSLATIONAL ONCOLOGY, 2022, 19
  • [10] Combining Dasatinib and AC220 Reduces Stroma-Based pSTAT5Y694 in FLT3-ITD+ AML and Overcomes FLT3 TKI Resistance
    Patel, Ami B.
    Pomicter, Anthony D.
    Yan, Dongqing
    Eiring, Anna M.
    Franzini, Anca
    O'Hare, Thomas
    Deininger, Michael W.
    BLOOD, 2018, 132
12